Denmark is experiencing remarkable economic growth driven by a significant increase in pharmaceutical exports. Economists have termed this surge as exceptional, although projections indicate a weakening in growth for this year. The looming risks associated with U.S. tariffs on the pharmaceutical sector may not significantly impede this growth trend, according to insights from the International Monetary Fund. Understanding these dynamics can provide valuable insights for market analysts and investors alike.